Pajson Agro India Limited has submitted the Monitoring Agency Report for the quarter ended June 30, 2026.

To, Date: 08.08.2026 The Corporate Relations Department BSE Limited P. J. Towers, Dalal Street, Mumbai-40000, Maharashtra Scrip Code: 544657 Sub: Monitoring Agency Report for the quarter ended June 30, 2026 (Q1FY27) Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘Listing Regulations’), read with Regulation 262 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we hereby submit the Monitoring Agency Report dated August 07, 2026, issued by Care Ratings Limited, Monitoring Agency, for the quarter ended on June 30, 2026 (Q1FY27) in respect of utilization of proceeds of the Initial Public Offer of the Company. The above information will be made available on the website of the Company https://www.pajsonagro.com We request you to kindly take the aforesaid information on record. Thanking you, Yours faithfully For Pajson Agro India Limited (Formerly Pajson Agro India Pvt Ltd) Roopal Saxena Compliance Officer & Company Secretary Membership No. A69189 PAJSON AGRO INDIA LIMITED (Formerly Pajson Agro India Private Limited) Head Office: 510, 5th Floor, Pearls Omaxe Tower-II, Netaji Subhash Place, Pitampura, Delhi-110034 India Processing Unit : Janakiramapuram, Rolugunta, Visakhapatnam- Andhra Pradesh 531114, India Phone – 011 43026646 Email: info@pajsonagro.com, CIN: L01100DL2021PLC386740 Website: www.pajsonagro.com No. CARE/NRO/GEN/2026-27/1089 The Board of Directors Pajson Agro India Limited 510, 5th Floor, Pearl Omaxe Tower Netaji Subash Place Pitampura Delhi August 07, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the IPO of Pajson Agro India Limited (“the Company”) We write in our capacity of Monitoring Agency for the Initial Public Offer for the amount aggregating to ₹74.45 crore of the Company and refer to our duties cast under Regulation 262 of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026 as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated November 20, 2025. Request you to kindly take the same on records. Thanking you, Yours faithfully, Rajan Sukhija Associate Director Rajan.sukhija@careedge.in CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Noida, Off Eastern Express Highway, Sion (East), Mumbai - Gautam Budh Nagar, Uttar Pradesh -201301 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC0716 Report of the Monitoring Agency Name of the issuer: Pajson Agro India Limited For quarter ended: June 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: As per offer document, in case deployment under any object is less than proposed deployment, balance amount can be utilized towards general corporate purposes (GCP), subject to limit of 15% of amount raised or ₹10 crores, whichever is less. The company had revised the cost vide board resolution dated December 26, 2025, wherein ₹1.96 crores of balance of issue expenses were transferred to GCP, resulting in object for GCP increasing to ₹10.43 crores. Accordingly, the revised utilization exceeds the stipulated cap of ₹10 crores, with no corresponding approval on record for such excess. (b) Range of Deviation: Not Applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit-related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Rajan Sukhija Designation of Authorized person/Signing Authority: Associate Director CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Noida, Off Eastern Express Highway, Sion (East), Mumbai - Gautam Budh Nagar, Uttar Pradesh -201301 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC0716 1) Issuer Details: Name of the issuer : Pajson Agro India Limited Name of the promoter : Aayush Jain, Anjali Jain and Pulkit Jain Industry/sector to which it belongs : Fast Moving Consumer Goods (FMCG) 2) Issue Details Issue Period : December 11, 2025, to December 15, 2025 Type of issue (public/rights) : Initial Public Offer Type of specified securities : Equity Shares IPO Grading, if any : Not Applicable Issue size (in crore) : ₹74.45 crore 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency for Monitoring Agency Board of Directors preparation of report As per offer document, in case deployment Issue expense Rs. 8.98 cr. mentioned in the offer under any object is less than proposed document was on approximate basis the actual deployment, balance amount can be utilized expense was 7.02 cr. therefore the remaining towards general corporate purposes (GCP), Rs.1.96cr. was moved towards GCP which is subject to limit of 15% of amount raised or ₹10 authorized by the board vide resolution dated crores, whichever is less. The company had 26.12.2025 Management certificate, Chartered Whether all utilization is as per the revised the cost vide board resolution dated No Accountant certificate*, Bank disclosures in the Offer Document? December 26, 2025, wherein ₹1.96 crores of statement. balance of issue expenses were transferred to GCP, resulting in object for GCP increasing to ₹10.43 crores. Accordingly, the revised utilization exceeds the stipulated cap of ₹10 crores, with no corresponding approval on record for such excess. Whether shareholder approval has Not Applicable CA certificate*, Management Not Applicable CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Noida, Off Eastern Express Hig [Showing first 8,000 characters — download PDF for full document]